ロード中...
A mutational signature in gastric cancer suggests therapeutic strategies
Targeting defects in the DNA repair machinery of neoplastic cells, for example, those due to inactivating BRCA1 and/or BRCA2 mutations, has been used for developing new therapies in certain types of breast, ovarian and pancreatic cancers. Recently, a mutational signature was associated with failure...
保存先:
| 出版年: | Nat Commun |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918743/ https://ncbi.nlm.nih.gov/pubmed/26511885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms9683 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|